TELA Bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TELA Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • TELA Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $985K, a 9.63% decline year-over-year.
  • TELA Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $4.2M, a 12.6% decline year-over-year.
  • TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4.36M, a 13.3% decline from 2023.
  • TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.03M, a 26.1% increase from 2022.
  • TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.99M, a 8.96% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.36M -$670K -13.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 $5.03M +$1.04M +26.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 $3.99M +$328K +8.96% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-21
2021 $3.66M +$1.6M +77.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 $2.06M +$1.6M +350% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $457K +$241K +112% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-23
2018 $216K +$19K +9.65% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 $197K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.